معرفی
Helen Ross, MD is a Professor at Rush Medical College, Rush University, in the Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy. She currently serves as Interim Division Chief and Director of Cancer Research & Clinical Trials, demonstrating leadership in both academic and clinical research domains.
Her research interests focus on hematology, oncology, and cell therapy, with a strong emphasis on advancing cancer treatment through innovative clinical trials and translational research. These areas reflect her dual role as a clinician-scientist contributing to both patient care and scientific discovery.
The body of her recent scholarly work centers on cancer therapeutics, hematologic malignancies, and cellular immunotherapies. Though specific publications are not listed, her leadership in clinical trials suggests a robust research program with translational impact across oncology disciplines.
- No scientific awards listed.
Dr. Ross mentors trainees and leads a research team focused on cancer clinical trials, though specific advisees are not named. She oversees major research initiatives and grants related to cancer therapeutics and clinical trial development through her directorship. Her leadership in securing and managing research funding underscores her role as a principal investigator in oncology research.
She leads the Cancer Research & Clinical Trials program, which likely involves a multidisciplinary team of investigators, coordinators, and clinicians focused on designing and implementing novel therapeutic trials in hematology and oncology.
